General Biologicals Corporation (TPEX:4117)
Taiwan · Delayed Price · Currency is TWD 12.70
-0.90 (-6.62%)
Jun 18, 2026, 2:59 PM CST
General Biologicals Market Cap
General Biologicals has a market cap or net worth of 772.48 million as of June 18, 2026. Its market cap has decreased by -35.37% in one year.
Market Cap
772.48M
Enterprise Value
2.58B
Revenue
215.74M
Ranking
n/a
PE Ratio
1.71
Stock Price
12.70
Market Cap Chart
Since February 21, 2005, General Biologicals's market cap has increased from 326.98M to 772.48M, an increase of 136.25%. That is a compound annual growth rate of 4.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 772.48M | -1.17% |
| Dec 31, 2025 | 781.60M | -38.66% |
| Dec 31, 2024 | 1.27B | -21.11% |
| Dec 29, 2023 | 1.62B | 0.37% |
| Dec 30, 2022 | 1.61B | -22.70% |
| Dec 30, 2021 | 2.08B | -35.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeneFerm Biotechnology | 1.41B |
| InnoPharmax | 1.24B |
| Excelsior Biopharma | 1.16B |
| Prince Pharmaceutical | 1.13B |
| Winston Medical Supply | 1.12B |
| DV Biomed | 998.32M |
| Anxo Pharmaceutical | 949.81M |
| Mediera | 882.95M |